This is basically confirming what was discovered in Australia towards the end of last year.
"Here, we used a case-control approach to monitor SARS-CoV-2 genomes through time in nine immunocompromised -patients with five treated with Molnupiravir. Within days of treatment, we detected a large number of low-frequency mutations in patients …
This is basically confirming what was discovered in Australia towards the end of last year.
"Here, we used a case-control approach to monitor SARS-CoV-2 genomes through time in nine immunocompromised -patients with five treated with Molnupiravir. Within days of treatment, we detected a large number of low-frequency mutations in patients and that these new mutations could persist and, in some cases, were fixed in the virus population. All patients treated with the drug accrued new mutations in the spike protein of the virus, including non-synonymous mutations that altered the amino acid sequence"
It is inevitable that some of the forced mutations in some people taking Molnupravir would have enhanced fitness leading to this. How it was ever licenced is yet another example of Big Pharma converting the health care into sick care.
It's a shame the Australian TGA rubber-stamps the FDA CDC experimental products. A script for Merck's Lagevrio/molnupiravir 40 capsules costs $1,101.39.
This is basically confirming what was discovered in Australia towards the end of last year.
"Here, we used a case-control approach to monitor SARS-CoV-2 genomes through time in nine immunocompromised -patients with five treated with Molnupiravir. Within days of treatment, we detected a large number of low-frequency mutations in patients and that these new mutations could persist and, in some cases, were fixed in the virus population. All patients treated with the drug accrued new mutations in the spike protein of the virus, including non-synonymous mutations that altered the amino acid sequence"
https://www.medrxiv.org/content/10.1101/2022.12.21.22283811v1.full.pdf
Igor Chudov wrote about it - https://igorchudov.substack.com/p/study-confirms-that-molnupiravir
It is inevitable that some of the forced mutations in some people taking Molnupravir would have enhanced fitness leading to this. How it was ever licenced is yet another example of Big Pharma converting the health care into sick care.
It's a shame the Australian TGA rubber-stamps the FDA CDC experimental products. A script for Merck's Lagevrio/molnupiravir 40 capsules costs $1,101.39.